Moderna Inc reported 10.97B in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 645.73M 28.25M
Agios Pharmaceuticals AGIO:US $ 1702.56M 652.55M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Amgen AMGN:US $ 19099M 2200M
Arrowhead Research ARWR:US $ 525.96M 60.8M
Biogen BIIB:US $ 7183.7M 464.2M
Biomarin Pharmaceutical BMRN:US $ 2357.84M 69.07M
Bluebird Bio BLUE:US $ 903.53M 194.01M
Esperion Therapeutics ESPR:US $ 275.17M 2.6M
Gilead Sciences GILD:US $ 14498M 1220M
GlaxoSmithKline GSK:LN 17.57B 958M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Intercept Pharmaceuticals ICPT:US $ 493.1M 5.54M
IONIS PHARMACEUT IONS:US $ 2238.42M 249M
Mirati Therapeutics MRTX:US $ 1278.09M 25.42M
Puma Biotechnology PBYI:US $ 167.75M 3.99M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M
Sangamo Biosciences SGMO:US $ 554.06M 52.88M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Seattle Genetics SGEN:US $ 3098.51M 5.18M
Ultragenyx Pharmaceutical RARE:US $ 949.49M 121.44M
United Therapeutics UTHR:US $ 2317.9M 303.6M
Vertex Pharmaceuticals VRTX:US $ 8457.51M 81.79M
YTE INCY:US $ 2620.06M 170.09M